A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocolNicholas F. Brown, Paul Mulholland, Leena Elhussein et al.|BMC Cancer|2020Cited by 51